Certificate of Analysis available for every lot≥99% purity, HPLC & mass-spec verifiedFor research use only. Not for human consumption.Tirzepatide is a synthetic 39-amino-acid peptide modified with a C20 fatty acid chain and non-coded Aib residues. It is studied as a dual agonist of the GIP and GLP-1 receptors, two incretin hormone pathways involved in glucose-dependent insulin signaling.
Molecular Formula: C62H98N16O22
Molecular Weight: 1419.556 g/mol
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
CAS #: 137525-51-0
Purity: 99% HPLC
Studied in cell and clinical-literature contexts around incretin receptor signaling, beta-cell function, insulin sensitivity and lipid and metabolic biomarkers.
The peptide engages both the GIP receptor and the GLP-1 receptor. Published pharmacology describes it as an imbalanced and biased agonist, with stronger effect at the GIP receptor, and describes a transient delay in gastric emptying similar to selective GLP-1 receptor agonists.
Receptor-signaling studies compare the response at the two receptors. Other work examines beta-cell function and insulin sensitivity biomarkers and lipoprotein markers in published trial datasets.
Supplied as a lyophilized powder. Identity and purity are normally confirmed by HPLC and mass spectrometry. Refer to the Certificate of Analysis for the lot you receive.
Peptides are shipped lyophilized (freeze-dried), a state that keeps them stable in transit. Keep vials cold and away from light on arrival.
Young Body supplies research compounds exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
